Effectiveness of influenza vaccination in working-age adults with diabetes: A population-based cohort study

Thorax

Volumn 68, Issue 7, 2013, Pages 658-663

  Lau, Darren ^a   Eurich, Dean T ^a   Majumdar, Sumit R ^a   Katz, Alan ^b   Johnson, Jeffrey A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGE DISTRIBUTION; ARTICLE; CANADA; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PNEUMONIA; POPULATION BASED CASE CONTROL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEX DETERMINATION; WORKER;

CLINICAL EPIDEMIOLOGY; VIRAL INFECTION;

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MANITOBA; MIDDLE AGED; MORBIDITY; POPULATION SURVEILLANCE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; VACCINATION; YOUNG ADULT;

EID: 84879415876     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-203109     Document Type: Article

References (35)

1. Schanzer DL, Langley JM, Tam TWS. Co-morbidities associated with influenza-attributed mortality, 1994-2000, Canada. Vaccine 2008;26:4697-703.
2. National Advisory Committee on Immunizations. Statement on seasonal influenza vaccine for 2011-2012. Can Commun Dis Rep Wkly 2011;37:1-55.
3. Advisory Committee on Immunization Practices. Prevention and control of influenza with vaccines. Morb Mortal Wkly Rep 2010;59:1-62.
4. Smith SA, Poland GA. Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care 2000;23:95-108. (Pubitemid 30022903)
5. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care 2009;32:S13-S61.
6. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Influenza and pneumococcal immunizations. Can J Diabetes 2008;32:S86-7.
7. Nichol KL, Zimmerman R. Generalist and subspecialist physicians' knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients: a nationwide survey. Arch Intern Med 2001;161:2702-8. (Pubitemid 33134846)
8. Szilagyi PG, Shone LP, Barth R, et al. Physician practices and attitudes regarding adult immunizations. Prev Med 2005;40:152-61. (Pubitemid 39468605)
9. Hak E, Nordin J, Wei F, et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis 2002;35:370-7. (Pubitemid 34852565)
10. Heymann AD, Shapiro Y, Chodick G, et al. Reduced hospitalizations and death associated with influenza vaccination among patients with and without diabetes. Diabetes Care 2004;27:2581-4. (Pubitemid 39441454)
11. Colquhoun AJ, Nicholson KG, Botha JL, et al. Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes. Epidemiol Infect 1997;119:335-41. (Pubitemid 28025290)
12. Looijmans-Van den Akker I, Verheij TJ, Buskens E, et al. Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients. Diabetes Care 2006;29:1771-6. (Pubitemid 44156628)
13. Jefferson T, Rivetti D, Rivetti A, et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005;366:1165-74. (Pubitemid 41393594)
14. Nichol KL, Nordin JD, Nelson DB, et al. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007;357:1373-81. (Pubitemid 47535592)
15. Jackson LA, Jackson ML, Nelson JC, et al. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006;35:337-44.
16. Manuel DG, Schultz SE. Health-related quality of life and health-adjusted life expectancy of people with diabetes in Ontario, Canada, 1996-1997. Diabetes Care 2004;27:407-14. (Pubitemid 38174065)
17. Neuzil KM, Reed GW, Mitchel EF Jr., et al. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 1999;281:901-7. (Pubitemid 29124633)
18. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004;292:1333-40. (Pubitemid 39223224)
19. Schanzer DL, Langley JM, Tam TWS. Role of influenza and other respiratory viruses in admissions of adults to Canadian hospitals. Influenza Other Respi Viruses 2008;2:1-8.
20. Nelson JC, Jackson ML, Weiss NS, et al. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol 2009;62:687-94.
21. Manitoba Centre for Health Policy. Population Health Research Data Repository, Administrative Health Databases. Winnipeg, Manitoba: Manitoba Centre for Health Policy. 2011. http://www.umanitoba.ca/faculties/medicine/units/ community-health-sciences/departmental-units/mchp/resources/repository/ health-admin.html (accessed 24 Jun 2011).
22. Hilderman T, Katz A, Derksen S, et al. Manitoba immunization study. Winnipeg, MB: Manitoba Centre for Health Policy, 2011:1-229.
23. Blanchard JF, Ludwig S, Wajda A, et al. Incidence and prevalence of diabetes in Manitoba, 1986-1991. Diabetes Care 1996;19:807-11. (Pubitemid 26286983)
24. Hottes TS, Skowronski DM, Hiebert B, et al. Influenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for bias. PLoS ONE 2011;6:e22618.
25. Belongia E, Irving S, Waring S, et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA 2010;304:1091-8.
26. Tsui FC, Wagner MM, Dato V, et al. Value of ICD-9 coded chief complaints for detection of epidemics. Proc AMIA Symp 2001:711-15.
27. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992;82:703-10.
28. Reid RJ, MacWilliam L, Verhulst L, et al. Performance of the ACG case-mix system in two Canadian provinces. Med Care 2001;39:86-99.
29. Sander B, Kwong JC, Bauch CT, et al. Economic appraisal of Ontario's universal influenza immunization program: a cost-utility analysis. PLoS Med 2010; 7:e1000256.
30. Jefferson T, Di Pietrantonj C. Inactivated influenza vaccines in the elderly-are you sure? Lancet 2007;370:1199-200. (Pubitemid 47503285)
31. Eurich DT, Marrie TJ, Johnstone J, et al. Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: Pleiotropic benefits or residual confounding? Am J Respir Crit Care Med 2008;178:527-33.
32. Jackson LA, Nelson JC, Benson P, et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 2006;35:345-52.
33. Jefferson T. Influenza vaccination: policy versus evidence. BMJ 2006; 333:912-15. (Pubitemid 44683514)
34. Jefferson T, Di Pietrantonj C, Rivetti A, et al. Vaccines for preventing influenza in healthy adults. Cochrane Libr 2010:1-119.
35. Simonsen L, Viboud C, Taylor RJ, et al. Influenza vaccination and mortality benefits: new insights, new opportunities. Vaccine 2009;27:6300-4.